Atlanta VA Medical Center

Summary

Atlanta VA Medical Center is a medical facility located in Decatur, Georgia. This center is recognized for care of Prostate Cancer, Lung Cancer, Post-Traumatic Stress Disorder, Coronary Artery Disease, Cancer and other specialties. Atlanta VA Medical Center is involved with conducting 302 clinical trials across 449 conditions. There are 33 research doctors associated with this hospital, such as Wayne B. Harris, MD, Gautam Kumar, MD, Joe R. Nocera, PhD, and Jeanie Park, MD.

Top PIs

Clinical Trials running at Atlanta VA Medical Center

Prostate Cancer

Post-Traumatic Stress Disorder

Cardiovascular Disease

Chronic Kidney Disease

Bladder Cancer

Lung Cancer

Colorectal Cancer

Small Cell Lung Cancer

Alcohol-Related Intimate Partner Violence

Alcoholism

High Dose Testosterone

for Prostate Cancer

This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically unstable because of DNA repair deficiency and this is a prospective study to test that hypothesis

Recruiting

3 awards

Phase 2

Docetaxel + Hormone Therapy

for Prostate Cancer

This study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs? This study would like to find out if this approach is better or worse than the usual approach for prostate cancer. The usual approach for patients who are not in a study is hormone treatment with Androgen Deprivation Therapy (ADT) and Androgen-Receptor Pathway Inhibitor (ARPI).

Recruiting

2 awards

Phase 3

5 criteria

Standard Therapy + Surgery/Radiation

for Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.

Recruiting

2 awards

Phase 3

30 criteria